These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23415934)

  • 1. Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism.
    Jalali-Nadoushan M; Roghani M
    Brain Res; 2013 Apr; 1505():68-74. PubMed ID: 23415934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
    Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
    Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.
    Zare K; Eidi A; Roghani M; Rohani AH
    Metab Brain Dis; 2015 Feb; 30(1):205-13. PubMed ID: 25123753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model.
    Sedaghat R; Roghani M; Khalili M
    Iran J Pharm Res; 2014; 13(1):227-34. PubMed ID: 24734075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.
    Afshin-Majd S; Khalili M; Roghani M; Mehranmehr N; Baluchnejadmojarad T
    Mol Neurobiol; 2015; 51(3):1064-70. PubMed ID: 24939694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model.
    Baluchnejadmojarad T; Roghani M; Nadoushan MR; Bagheri M
    Phytother Res; 2009 Jan; 23(1):132-5. PubMed ID: 18693302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
    Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
    Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.
    Baluchnejadmojarad T; Roghani M; Mafakheri M
    Neurosci Lett; 2010 Aug; 480(3):206-10. PubMed ID: 20600617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
    Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
    Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
    J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions.
    Truong L; Allbutt H; Kassiou M; Henderson JM
    Behav Brain Res; 2006 Apr; 169(1):1-9. PubMed ID: 16413939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Metz GA; Tse A; Ballermann M; Smith LK; Fouad K
    Eur J Neurosci; 2005 Aug; 22(3):735-44. PubMed ID: 16101755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
    Inden M; Kitamura Y; Kondo J; Hayashi K; Yanagida T; Takata K; Tsuchiya D; Yanagisawa D; Nishimura K; Taniguchi T; Shimohama S; Sugimoto H; Akaike A
    J Neurochem; 2005 Nov; 95(4):950-61. PubMed ID: 16135081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
    Roghani M; Behzadi G
    Brain Res; 2001 Feb; 892(1):211-7. PubMed ID: 11172767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
    Haghdoost-Yazdi H; Piri H; Faraji A; Fraidouni N; Dargahi T; Mahmudi M; Alipour Heidari M
    Neurol Res; 2016 Apr; 38(4):294-300. PubMed ID: 27098232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.